RESMED INC - COM (RMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RMD on NYSE
CUSIP
761152107
Type / Class
Equity / COM
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
92M
Holdings value
$23.7B
% of all portfolios
0.017%
Grand Portfolio weight change
0%
Number of holders
907
Number of buys
460
Number of sells
-391
Average Value change %
0%
Average buys %
+0.003%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of RESMED INC - COM (RMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.04M $558M -$35.7M $273.73 138
2025 Q2 92M $23.7B -$263M $258.00 907
2025 Q1 93.2M $20.8B +$661M $223.85 869
2024 Q4 90M $20.6B +$632M $228.69 853
2024 Q3 86.2M $21B +$210M $244.12 791
2024 Q2 85.5M $16.4B +$749M $191.42 767
2024 Q1 81.3M $16.1B +$226M $198.03 711
2023 Q4 182K $31.3M -$3.02M $172.02 8
2023 Q3 83.9M $12.4B -$1.76B $147.87 634
2023 Q2 93.6M $20.4B -$398M $218.50 712
2023 Q1 93.9M $20.6B +$84.8M $218.99 654
2022 Q4 95.1M $19.8B -$194M $208.13 705
2022 Q3 95.6M $20.9B -$39.7M $218.30 636
2022 Q2 87.6M $18.4B -$308M $209.63 650
2022 Q1 95.7M $23.2B +$474M $242.51 646
2021 Q4 93.5M $24.3B -$535M $260.48 693
2021 Q3 91.5M $24.1B -$134M $263.55 667
2021 Q2 95.5M $23.5B -$379M $246.52 644
2021 Q1 97.2M $18.8B -$166M $194.02 644
2020 Q4 96.2M $20.4B +$93.4M $212.56 641
2020 Q3 98.7M $16.9B -$315M $171.43 603
2020 Q2 100M $19.3B +$661M $192.00 559
2020 Q1 98.1M $14.4B +$118M $147.29 562
2019 Q4 97.6M $15.1B +$119M $154.97 546
2019 Q3 95.1M $12.8B +$73.8M $135.11 508
2019 Q2 95.8M $11.7B +$165M $122.03 470
2019 Q1 95.6M $9.94B -$36.5M $103.97 460
2018 Q4 97.4M $11.1B +$391M $113.87 484
2018 Q3 92.3M $10.6B +$169M $115.34 478
2018 Q2 90.9M $9.41B +$295M $103.58 450
2018 Q1 90.2M $8.88B +$133M $98.47 433
2017 Q4 88.9M $7.53B +$195M $84.69 404
2017 Q3 88.7M $6.83B +$167M $76.96 355
2017 Q2 86.6M $6.74B +$38M $77.87 330
2017 Q1 86.7M $6.24B +$814M $71.97 362
2016 Q4 87.9M $5.46B -$130M $62.05 352
2016 Q3 90M $5.83B +$155M $64.79 366
2016 Q2 86.9M $5.5B +$264M $63.23 354
2016 Q1 83.3M $4.82B +$32.6M $57.82 363
2015 Q4 82.6M $4.43B +$286M $53.69 341
2015 Q3 77.1M $3.92B +$122M $50.96 305
2015 Q2 73.3M $4.13B +$8.31M $56.37 307
2015 Q1 73.3M $5.26B -$62.6M $71.78 325
2014 Q4 74.7M $4.19B +$75.2M $56.06 306
2014 Q3 72.7M $3.58B -$145M $49.27 296
2014 Q2 75.6M $3.83B -$208M $50.63 308
2014 Q1 79.9M $3.57B +$5.45M $44.69 316